Gilead launches global ALL4LIVER grant program to help achieve the world health organization’s goal of viral hepatitis elimination by 2030. Gilead Sciences, Inc. (Nasdaq: GILD)
Third Sector acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.